Discover how researchers are using Affymetrix products and services to power their experiments in the Featured Researchers. This community features scientists who will share their work with you through hands-on activities and conversation. Learn how scientists detect cancer-causing genes, advance breeding methods in plants and animals, and more.
Alan Landay, PhD, Chairperson of the Department of Immunology and Microbiology at Rush Medical College, discusses his research on aging and non-HIV comorbidities in HIV patients.
Gerald Wertheim, MD, PhD, Assistant Professor of Pathology and Laboratory Medicine at the Childrens Hospital of Philadelphia, discusses a novel approach to simultaneously analyze DNA methylation patterns at multiple target loci in order to predict leukemia prognosis.
Mady Hornig, MA, MD, Director of Translational Research discusses the use multiplexed immunoassays for studying chronic fatigue syndrome, known as myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS).
Donald Durden, MD, PhD, Vice Chair for Research of the Department of Pediatrics at the University of California, San Diego (UCSD) and Associate Director for Pediatric Oncology at the Moores UCSD Cancer Center, discusses how multi-omics will progress cancer research and improve treatments.
Jizeng Jia, PhD, from the Institute of Crop Sciences, Chinese Academy of Agriculture Science, Beijing, discusses the limitations of current technologies and how they were overcome to develop the highest density wheat array commercially available.
Gordon Mills, MD, PhD, of the University of Texas MD Anderson Cancer Center and "Dream Team" co-leader in Stand Up To Cancer®, discusses the importance of genomic profiling in the discovery of novel predictive markers to improve the effectiveness of cancer treatment.
Professor Mark McCarthy, from the University of Oxford, UK, outlines how the intersection of biobank capabilities, new study designs, and technological advances will improve our understanding of complex trait genetics.
Bruno Stuhlmüller, PhD, discusses how he is successfully finding mRNA and miRNA biomarkers from whole blood to help predict the best therapy option for rheumatoid arthritis patients.
Dr. Peter Ambros from the Children's Cancer Research Institute (CCRI) in Vienna, Austria discusses the way in which arrays are helping to unravel the complexities of the cancer genome and guiding patient-tailored treatment strategies.
Austin Tanney, PhD, Scientific Liaison Manager for Almac Diagnostics, UK, discusses the opportunities and challenges of working with FFPE tissue, and his visions for technologies driving towards personalized medicine.
Procter & Gamble Company's Jay Tiesman, PhD, discusses the role of genomics in the cosmetics industry.
The University of Utah's Joshua Schiffman, MD, discusses the use of molecular inversion probe (MIP) technology for studying copy number alterations in pediatric cancers.
The University of Miami's Lisa Baumbach and Maastricht University's Torik Ayoubi discuss how ethnicity-specific genetic changes govern aggressive breast cancer risks.
Chris Smith of Cambridge University, Tyson Clark of Affymetrix and Melissa Cline of UCSC discuss EURASNET's approach for comparing commercial microarrays.
Rob Norgren of The University of Nebraska Medical Center and Katja Nowick of Lawrence Livermore National Laboratory discuss the development of the Rhesus Macaque Genome Array.
Yong-Jie Lu of Queen Mary, University of London and Colleen Elso of the Walter and Eliza Hall Institute discuss a method for rapidly identifying chromosome rearrangements.